The White House has scheduled a meeting for next week with a cannabis biotechnology company executive regarding a proposed enforcement policy for CBD products. The Office of Information and Regulatory Affairs (OIRA) under the White House Office of Management and Budget (OMB) announced earlier this month that it plans to review yet-unpublished guidance titled “Cannabidiol […]